This site has been produced by Kite, a Gilead Company

Three Important Reminders

1. Driving after treatment

After your CAR T-cell therapy treatment, you won’t be allowed to drive for at least 8 weeks after the infusion. This is a precaution in case of side effects. It can be helpful to make sure you have someone to drive you to and from appointments ahead of your treatment.

2. What to do about side effects

Tell your healthcare team immediately if you notice any change in how you’re feeling or any side effects occur after your infusion.

Your cell therapy team will monitor you for side effects in the weeks following your treatment. It’s also important that you make note of any side effects in ‘Your Treatment Journal’ in the first few weeks after your infusion. You may want to ask someone to help you with this.

Responding quickly to any change in your condition can prevent side effects becoming more serious.

3. Carry your Patient Alert Card

You will have been given a Patient Alert card by your healthcare team. Make sure to carry this with you and show it to any healthcare professionals you see after your treatment.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

United Kingdom: Reporting of side effects

For patients residing in the United Kingdom, you can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of your medicine.

Republic of Ireland: Reporting of side effects

For patients residing in the Republic of Ireland, you can also report side effects directly via the HPRA website at www.hpra.ie. By reporting side effects, you can help provide more information on the safety of your medicine.

This site is a patient information resource, intended only for patients residing in the United Kingdom and Ireland who are being referred for or have been prescribed CAR T-cell therapy by their healthcare professional. This site has been developed and paid for by Kite, a Gilead Company.

This site has been produced by Kite, a Gilead Company

© 2024 Gilead Sciences, Inc. All rights reserved. KITE and the Kite logo are registered trademarks of Kite Pharma, Inc | GILEAD is a registered trademark of Gilead Sciences, Inc and its related companies

UK-UNB-3797 April 2023